Lisa M. Nilsson

3.5k total citations · 1 hit paper
52 papers, 2.6k citations indexed

About

Lisa M. Nilsson is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lisa M. Nilsson has authored 52 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 25 papers in Oncology and 21 papers in Immunology. Recurrent topics in Lisa M. Nilsson's work include Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Histone Deacetylase Inhibitors Research (9 papers). Lisa M. Nilsson is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Histone Deacetylase Inhibitors Research (9 papers). Lisa M. Nilsson collaborates with scholars based in Sweden, Australia and United States. Lisa M. Nilsson's co-authors include Jonas A. Nilsson, Ulrich Keller, Lars Ny, Henrik Jespersen, Somsundar Veppil Muralidharan, Anetta Härtlová, Nelson O. Gekara, Torben Ek, Saskia F. Erttmann and Ulrike Resch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Lisa M. Nilsson

50 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA Damage Primes the Type I Interferon System via the Cytosolic DNA Sensor STING to Promote Anti-Microbial Innate Immunity

2015 537 citations Anetta Härtlová, Saskia F. Erttmann et al. Immunity profile →

Peers

Countries citing papers authored by Lisa M. Nilsson

Since Specialization

Citations

This map shows the geographic impact of Lisa M. Nilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Nilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Nilsson more than expected).

Fields of papers citing papers by Lisa M. Nilsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa M. Nilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Nilsson. The network helps show where Lisa M. Nilsson may publish in the future.

Co-authorship network of co-authors of Lisa M. Nilsson

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa M. Nilsson. A scholar is included among the top collaborators of Lisa M. Nilsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa M. Nilsson. Lisa M. Nilsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insulin Sensitivity Controls Activity of Pathogenic CD4+ T Cells in Rheumatoid Arthritis 2024 ·Cells ·Malin C. Erlandsson, (unknown), (unknown), Karin Andersson, Lisa M. Nilsson, Sofia Töyrä Silfverswärd, Rille Pullerits, Maria Bokarewa	0
2	Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases 2023 ·eLife ·Joakim Karlsson, Vasu R. Sah, Roger Olofsson Bagge, Irina Kuznetsova, (unknown), Samuel Alsén, (unknown), Alka Saxena, Lars Ny, Lisa M. Nilsson, Jonas A. Nilsson	2
3	Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs 2023 ·Cancers ·(unknown), Rebecca Riise, (unknown), Joakim Karlsson, Samuel Alsén, (unknown), Akseli Hemminki, Roger Olofsson Bagge, Lars Ny, Lisa M. Nilsson, (unknown), Jonas A. Nilsson	16
4	Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma 2021 ·Melanoma Research ·Vasu R. Sah, Joakim Karlsson, Henrik Jespersen, Mattias F. Lindberg, Lisa M. Nilsson, Lars Ny, Jonas A. Nilsson	15
5	The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma 2021 ·Nature Communications ·Lars Ny, Henrik Jespersen, Joakim Karlsson, Samuel Alsén, Stefan Filges, Charlotta All‐Eriksson, Bengt Åndersson, Ana Carneiro, Hildur Helgadóttir, Max Levin, Ingrid Ljuslinder, Roger Olofsson Bagge, Vasu R. Sah, Ulrika Stierner, Anders Ståhlberg, Gustav Ullenhag, Lisa M. Nilsson, Jonas A. Nilsson	120
6	Small molecule inhibitors and a kinase-dead expressing mouse model demonstrate that the kinase activity of Chk1 is essential for mouse embryos and cancer cells 2020 ·Life Science Alliance ·Somsundar Veppil Muralidharan, Lisa M. Nilsson, Mattias F. Lindberg, Jonas A. Nilsson	4
7	Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse models 2020 ·Annals of Oncology ·Lars Ny, Larissa Yokota Rizzo, Valerio Belgrano, Joakim Karlsson, Henrik Jespersen, Louise Carstam, Roger Olofsson Bagge, Lisa M. Nilsson, Jonas A. Nilsson	30
8	Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study 2019 ·BMC Cancer ·Henrik Jespersen, Roger Olofsson Bagge, Gustav Ullenhag, Ana Carneiro, Hildur Helgadóttir, Ingrid Ljuslinder, Max Levin, Charlotta All‐Eriksson, Bengt Åndersson, Ulrika Stierner, Lisa M. Nilsson, Jonas A. Nilsson, Lars Ny	52
9	BET bromodomain inhibitors synergize with ATR inhibitors in melanoma 2017 ·Cell Death and Disease ·Somsundar Veppil Muralidharan, Berglind O. Einarsdottir, Joydeep Bhadury, Mattias F. Lindberg, (unknown), Eric Campeau, Roger Olofsson Bagge, Ulrika Stierner, Lars Ny, Lisa M. Nilsson, Jonas A. Nilsson	15
10	Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model 2017 ·Nature Communications ·Henrik Jespersen, Mattias F. Lindberg, Marco Donia, Elin Söderberg, Rikke Andersen, Ulrich Keller, Lars Ny, Inge Marie Svane, Lisa M. Nilsson, Jonas A. Nilsson	120
11	Cancer Differentiating Agent Hexamethylene Bisacetamide Inhibits BET Bromodomain Proteins 2016 ·Cancer Research ·Lisa M. Nilsson, (unknown), Somsundar Veppil Muralidharan, (unknown), M. Welin, Joydeep Bhadury, Derek T. Logan, Björn Walse, Jonas A. Nilsson	14
12	RNAi delivery by exosome-mimetic nanovesicles – Implications for targeting c-Myc in cancer 2016 ·Biomaterials ·Taral R. Lunavat, Su Chul Jang, Lisa M. Nilsson, Hyun Taek Park, Gabriela Repiská, Cecilia Lässer, Jonas A. Nilsson, Yong Song Gho, Jan Lötvall	186
13	DNA Damage Primes the Type I Interferon System via the Cytosolic DNA Sensor STING to Promote Anti-Microbial Innate Immunity breakdown → 2015 ·Immunity ·Anetta Härtlová, Saskia F. Erttmann, (unknown), (unknown), Ulrike Resch, (unknown), Stefan Lienenklaus, Lisa M. Nilsson, Andrea Kröger, Jonas A. Nilsson, Torben Ek, Siegfried Weiß, Nelson O. Gekara	537
14	Therapeutic Implications for the Induced Levels of Chk1 in Myc-Expressing Cancer Cells 2011 ·Clinical Cancer Research ·Andreas Höglund, Lisa M. Nilsson, Somsundar Veppil Muralidharan, Lisa Hasvold, Philip J. Merta, Martina Rudelius, Viktoriya D. Nikolova, Ulrich Keller, Jonas A. Nilsson	110
15	Skp2 Directs Myc-Mediated Suppression of p27Kip1 yet Has Modest Effects on Myc-Driven Lymphomagenesis 2010 ·Molecular Cancer Research ·Jennifer B. Old, Susanne Kratzat, Alexander Hoellein, (unknown), Jonas A. Nilsson, Lisa M. Nilsson, Keiichi I. Nakayama, Christian Peschel, John L. Cleveland, Ulrich Keller	26
16	Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis 2007 ·The EMBO Journal ·Ulrich Keller, Jennifer B. Old, Frank C. Dorsey, Jonas A. Nilsson, Lisa M. Nilsson, Kirsteen H. Maclean, Linda H. Chung, Chunying Yang, Charles Spruck, Kelli L. Boyd, Steven I. Reed, John L. Cleveland	81
17	Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis 2006 ·Oncogene ·Lisa M. Nilsson, Ulrich Keller, Chunying Yang, Jonas A. Nilsson, John L. Cleveland, Martine F. Roussel	5
18	Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation 2005 ·Cancer Cell ·Jonas A. Nilsson, Ulrich Keller, Troy A. Baudino, Chunying Yang, (unknown), (unknown), Lisa M. Nilsson, Geoffrey Neale, Debora L. Kramer, Carl W. Porter, John L. Cleveland	166
19	Effects of staurosporine, U-73122, wortmannin, 4-hydroxynonenal and sodium azide upon the release of secreted β-amyloid precursor protein from human platelets in response to thrombin stimulation 2001 ·Molecular and Cellular Biochemistry ·(unknown), Lisa M. Nilsson, Christopher Fowler	5
20	Structural Basis of SH2 Domain Mutations in X-Linked Agammaglobulinemia 1994 ·Biochemical and Biophysical Research Communications ·Mauno Vihinen, Lisa M. Nilsson, Smith Rjh	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact